Muscarinic agonists for schizophrenia: Bridging preclinical evidence and clinical enthusiasm

British Journal of Pharmacology · Published 2026-08-04 · DOI 10.1111/bph.70582

Free full text

Authors (2)

Brian J. Morris, Judith A. Pratt

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Morris, B., Pratt, J. (2026). Muscarinic agonists for schizophrenia: Bridging preclinical evidence and clinical enthusiasm. British Journal of Pharmacology. https://doi.org/10.1111/bph.70582

Related articles

• Activation of sigma non‐opioid intracellular receptor 1 (S1R) receptor inhibits plexin domain containing 2 (Plxdc2) driven microglial inflammation to ameliorate depressive‐like behaviours in mice · British Journal of Pharmacology · 2026 · Same journal
• Acute anaphylactic and multiorgan inflammatory effects of Comirnaty in pigs: evidence of spike protein mRNA transfection and paralleling inflammatory cytokine upregulation · British Journal of Pharmacology · 2026 · Same journal
• A novel quinoline and manganese‐based carbon monoxide‐releasing molecule for intravesical therapy of bladder cancer · British Journal of Pharmacology · 2026 · Same journal
• Serotonin engages divergent 5‐HT receptor pathways for cell type‐resolved modulation of prefrontal layer 5 microcircuits · British Journal of Pharmacology · 2026 · Same journal
• Decoding functional specialization in G protein‐coupled receptors (GPCRs) through evolution‐guided residue profiling · British Journal of Pharmacology · 2026 · Same journal
• Arrhythmias associated with immune checkpoint inhibitor therapy—A clinical perspective · British Journal of Pharmacology · 2026 · Same journal
• Thirty‐day dapagliflozin therapy improves the nanomechanical properties of red blood cells in patients with type 1 diabetes · British Journal of Pharmacology · 2026 · Same journal
• Targeting sphingosine‐1‐phosphate receptor‐2 attenuates spinal cord injury by preventing neuronal ferroptosis · British Journal of Pharmacology · 2026 · Same journal
• Virtual cell construction for artificial intelligence‐driven drug discovery · British Journal of Pharmacology · 2026 · Same journal
• A covalent peptide engager approach to equip immunotherapeutic monoclonal and pan IgG serum antibodies with new tumour‐targeting function · British Journal of Pharmacology · 2026 · Same journal